Breast Cancer

Latest News


Today women face a plethora of options. Their tumors are tested for all kinds of differences that may tell them if chemotherapy will work and which drugs would work best. There are support groups and help for families that we didn’t have.

Lynparza (olaparib) was granted approval by the Food and Drug Administration (FDA) for the treatment of patients with BRCA-positive, HER2-negative metastatic breast cancer who have previously received chemotherapy. Also, patients who have HR-positive disease should have prior endocrine therapy or they would not be considered appropriate for such treatment.

Those of us who had chemotherapy and/or radiation as part of our treatment have now been hit with another lovely late effect, if the results of a new study are accurate. We have the potential to age prematurely.

The after effects of breast cancer can leave survivors wondering how much more medical trauma they can take. The daily struggle presents challenges for many survivors. This is one survivor's story.